Metabolic & Cardiometabolic
oxidized linoleic-acid metabolites (OxLAMs, e.g. 9-/13-HODE) causes atherosclerosis
In plain terms: Do the oxidized fats from seed oils clog your arteries?
OxLAMs are present in plaque and have some pro-atherogenic actions, but several are also anti-inflammatory and dietary linoleic acid is linked to LOWER heart-disease risk, so the simple "seed-oil OxLAMs cause atherosclerosis" story is not supported.
Evidence ladder
How far up the ladder this claim has climbed. A high consensus on a low rung means "consistent so far," not "proven in people."
Top evidence so far: All trials, pooled (Meta-analysis)
How the studies fall
The evidence (12)
| Source | Grade | Stance | Quality | Finding |
|---|---|---|---|---|
| Han 2000 · J Clin Invest | in-vitro | supports | moderate | OxLDL-derived 9-/13-HODE activate PPARgamma, lower monocyte CCR2, may retain monocytes in lesion — a plausible pro-atherogenic mechanism. |
| Farvid 2014 · Circulation | meta-analysis | contradicts | high | Meta-analysis of prospective cohorts found higher dietary linoleic acid intake associated with a 15% lower coronary heart disease risk, contradicting the artery-clogging claim. |
| Nielsen 2021 · Eur J Nutr | observational | contradicts | moderate | Adipose linoleic acid (long-term intake biomarker) not positively associated with myocardial infarction in Danish case-cohort. |
| Veno 2018 · J Am Heart Assoc | observational | contradicts | moderate | Higher adipose linoleic acid associated with LOWER risk of ischemic stroke; no signal that dietary LA loads arteries with harm. |
| Ren 2023 · Crit Rev Food Sci Nutr | meta-analysis | contradicts | high | Meta-analysis of 32 studies found higher blood linoleic acid associated with LOWER coronary heart disease and fatal-CHD risk, opposing the net dietary-seed-oil harm claim. |
| Wang 2018 · Prostaglandins Leukot Essent Fatty Acids | observational | mixed | high | Epidemiology: higher dietary n-6/linoleic acid intake associated with LOWER CVD risk, opposite to a net-atherogenic OxLAM effect. |
| Ochin 2022 · J Lipid Atheroscler | animal | mixed | low | Dietary oxidized linoleic acid altered hepatic and plasma long-chain fatty-acid distribution in mice, consistent with but not proving a plaque-promoting effect. |
| Bojic 2016 · Anal Bioanal Chem | animal | mixed | moderate | In hypercholesterolemic rabbit plaque, 9-/13-HODE among most abundant oxylipins; biomarkers of lesions, not shown to cause them. |
| Wittwer 2007 · Prostaglandins Leukot Essent Fatty Acids | mechanism | mixed | moderate | 15-LOX/HODE pathway is "janus-faced": pro-atherogenic LDL oxidation vs anti-inflammatory 13-HODE inhibiting leukocyte adhesion. |
| Ramsden 2013 · BMJ | RCT | mixed | moderate | Recovered Sydney-Diet-Heart RCT + meta-analysis: substituting LA-rich oils did not reduce (and may raise) CHD death — but no atherosclerosis-promotion mechanism confirmed. |
| Fu 2002 · Mol Cell Biochem | mechanism | supports | low | 9-HODE and 13-HODE from oxLDL induce ALBP/aP2 in THP-1 macrophages, accelerating cholesterol-ester accumulation in foam cells found in human plaques. |
| Nagy 1998 · Cell | mechanism | supports | moderate | Oxidized-LDL components 9-HODE and 13-HODE act as PPARgamma ligands driving macrophage foam-cell gene expression central to atherogenesis. |
Disagree, or know a study we missed?
We grade by evidence, not opinions. The way to weigh in is to point us to a study we haven't cited (check the evidence table above first), or to flag a problem with one we have. Every submission is reviewed; if it holds up, the grade updates and shows in Science Changes Its Mind.
Opens a short form. You'll sign in with Google so submissions are tied to a real account — we don't display your identity, and we only accept a link we can verify (PubMed, DOI, ClinicalTrials.gov).
Educational only, not medical advice. Grades and scores reflect published evidence weighted by study design and quality; see the methodology.